Tag Archive for: Leukemia and Lymphoma Society

LIVE Webinar | Coping With the Emotional Side Effects of AML

It is known that acute myeloid leukemia (AML) patients endure many physical challenges from their disease, treatment and side effects, but cancer can have a significant effect on emotional health too. How can patients cope with the complex set of emotions that accompany an AML diagnosis? How does emotional distress influence quality of life?

On January 25, 2019 at 2:00 PM Eastern Time (11:00 AM Pacific; 1:00 PM Central), a dynamic panel will join us for a virtual one-hour program to discuss important aspects of care for AML patients, with a focus on the emotional side effects, research on new treatments underway and finding suitable clinical trials. 

Viewers will hear from noted expert Dr. Thomas W. LeBlanc, from Duke University Hospital, who conducted an observational study of AML patients on the relationship between emotional well-being and prognostic understanding, to learn more about the emotional impact of AML. 

Register now for this free online webinar to find out more about:

  • Understanding the emotional and psychological effects of AML 
  • Healthy ways to cope with feelings of fear, anxiety and stress
  • Novel agents in development for AML
  • Advice for patients seeking clinical trials

Register Here

Host & Guests


Register Here

Emerging Research and Promising AML Treatment Approaches

As precision medicine allows doctors to be more and more attuned to a patient’s unique version of acute myeloid leukemia (AML), it’s critical to stay up-to-date with therapies targeted toward specific genetic mutations, because the standard of care may not provide the most benefit. What’s new in AML research?  How can your genetic profile influence treatment decisions? 

On Friday, December 21 at 3:00 PM Eastern (2:00 PM Central, 12:00 PM Pacific), leading experts will join us for a virtual 1-hour program to share recent breakthroughs in AML treatment and research announced at the 2018 American Society of Hematology (ASH) annual meeting. The panel will focus on new drug approvals, emerging clinical trial data and innovative, individualized approaches to treat distinct AML subtypes. How will these advances translate to the real world? Viewers will also learn how these developments will impact AML patients and other promising therapies in the pipeline.

Register now for this free online webinar to find out more about:

  • AML treatment news released at ASH 2018
  • How these novel agents will be used in real-world clinics
  • Genetic profiling and the role genetic markers play in AML disease course and treatment decisions
  • Important updates on AML clinical trial data
  • Where research is headed next

Register Here

Host & Guest